Derivative works — US Patent 8273735

Defensive Disclosure: Process for Preparing Benzazepine Compounds and Related Intermediates

Publication Date: April 26, 2026

Authors: Senior Patent Strategist & Research Engineer, Defensive Publishing Team

This document outlines derivative process technologies related to the synthesis of benzazepine compounds and their intermediates, building upon the principles disclosed in US Patent 8,273,735. The aim is to establish prior art for various modifications, extensions, and applications, thereby limiting the scope for future incremental patenting by competitors. This disclosure focuses on variations of the core chemical processes rather than the therapeutic application of the final compounds.

Derivatives of Independent Claim 1: Process for Preparing Benzazepine Compound (1)

(Reacting compound (2) with amide compound (3) in presence of a carbonylating agent)

1. Material & Component Substitution

Derivative 1.1: Heterogeneous Catalytic Carbonylation with Supported Precious Metals

Enabling Description: The reaction of a benzazepine compound (2) with an aryl halide amide compound (3) to yield benzazepine compound (1) is performed via heterogeneous catalytic carbonylation. Instead of soluble metal carbonyls or palladium complexes, a heterogeneous catalyst comprising palladium nanoparticles (1-10 nm diameter) immobilized on a high-surface-area support such as activated carbon, silica gel, or mesoporous alumina is utilized. The reaction proceeds under a CO atmosphere (1-10 bar) at elevated temperatures (80-180° C.) in a solvent such as N,N-dimethylformamide or N-methylpyrrolidone, in the presence of a non-coordinating base (e.g., DBU or triethylamine). This allows for easier catalyst separation and recycling.
```
graph TD
    A[Compound (2)] -->|React with CO| B(Supported Pd Catalyst)
    C[Amide Compound (3)] -->|Solvent, Base, Heat| B
    B --> D{Benzazepine Compound (1)}
    D --> E[Catalyst Separation]
    E --> F[Purification]
```

Derivative 1.2: Carbonylation via Photoredox Catalysis with Organic Dyes

Enabling Description: The carbonylation reaction is mediated by an organic photoredox catalyst, such as Eosin Y or Rhodamine B, under visible light irradiation (400-550 nm LED source). Compound (2) and amide compound (3) are reacted in a polar aprotic solvent (e.g., acetonitrile, DMSO) under 1 atm of CO gas. A sacrificial electron donor (e.g., Hantzsch ester) and a mild base (e.g., potassium carbonate) are included. The photoredox catalyst generates a reactive species, facilitating the CO insertion and subsequent coupling, operating at ambient temperature.
```
graph TD
    A[Compound (2)] -->|React| PC(Photoredox Catalyst + Light)
    C[Amide Compound (3)] -->|CO, Sacrificial Donor, Base| PC
    PC --> D{Benzazepine Compound (1)}
    D --> F[Purification]
```

Derivative 1.3: Supercritical CO2 as Solvent and Carbonylating Agent Precursor

Enabling Description: The synthesis of benzazepine compound (1) from compound (2) and amide compound (3) is conducted in supercritical carbon dioxide (scCO2) as both the solvent and a source of carbonylating agent (via in situ generation of CO or direct reactivity under specific conditions, or simply leveraging its solvent properties for CO delivery). The reaction is run at pressures exceeding 73.8 bar and temperatures above 31.1° C., typically at 100-200 bar and 100-200° C., in the presence of a palladium-based catalyst system (e.g., Pd(OAc)2 with phosphine ligand) and a base. The tunable solvent properties of scCO2 allow for facile product separation by depressurization.
```
graph TD
    A[Compound (2)] --> SC(scCO2 Environment)
    C[Amide Compound (3)] --> SC
    K[Pd Catalyst, Base] --> SC
    SC --> D{Benzazepine Compound (1)}
    D --> E[Depressurization Separation]
    E --> F[Purification]
```

2. Operational Parameter Expansion

Derivative 1.4: Microfluidic Flow Reactor for Continuous Carbonylation

Enabling Description: The carbonylation reaction is implemented in a continuous flow microfluidic reactor system. Reactant solutions of compound (2), amide compound (3), catalyst (e.g., Pd(PPh3)4), and base are pumped through microchannels (100-500 µm internal diameter) at controlled flow rates, typically 10 µL/min to 10 mL/min. CO gas is precisely introduced into the flow, ensuring rapid mixing and efficient gas-liquid mass transfer. The reaction temperature (80-150° C.) and pressure (1-10 bar CO) are precisely maintained within the microreactor, leading to short residence times (minutes to hours) and improved selectivity compared to batch processes.
```
graph LR
    A[Feed 1: Compound (2) + Catalyst] --> MFR(Microfluidic Reactor)
    B[Feed 2: Amide Compound (3) + Base] --> MFR
    C[CO Gas Inlet] --> MFR
    MFR --> D{Benzazepine Compound (1) Stream}
    D --> E[Downstream Processing]
```

Derivative 1.5: High-Pressure, Low-Temperature Carbonylation with Optimized Ligand

Enabling Description: The carbonylation of compound (2) with amide compound (3) is conducted under high CO pressure (20-50 bar) but at moderate temperatures (30-70° C.) to suppress side reactions and enhance product stability. This is achieved by utilizing a highly active palladium catalyst system featuring electron-rich, sterically demanding ligands (e.g., N-heterocyclic carbenes, bulky phosphines like P(t-Bu)3 or SPhos). The reaction proceeds in an anhydrous solvent (e.g., THF, 1,4-dioxane) in the presence of an inorganic base (e.g., Cs2CO3). The high CO concentration shifts equilibrium, enabling lower temperatures while maintaining reaction rates.
```
graph TD
    A[Compound (2)] --> R(High-Pressure Reactor)
    C[Amide Compound (3)] --> R
    K[Pd Catalyst + Bulky Ligand] --> R
    G[CO (20-50 bar)] --> R
    B[Base, Solvent] --> R
    R -->|30-70°C| D{Benzazepine Compound (1)}
    D --> F[Purification]
```

3. Cross-Domain Application

Derivative 1.6: Benzazepine Motif for Specialty Polymer Synthesis

Enabling Description: The carbonylation process described in Claim 1 is adapted to synthesize benzazepine-containing monomers (e.g., Formula (1) where R1 or R2 contains a polymerizable functional group like an acrylate or epoxide). These monomers are then incorporated into specialty polymers, for instance, as a functional cross-linking agent in advanced adhesive formulations or as a UV-curable component in protective coatings. The benzazepine moiety, potentially with its specific electronic or steric properties, confers unique mechanical or optical properties to the resulting polymer matrix.
```
graph TD
    A[Compound (2)-FG1] --> P(Polymer Synthesis)
    C[Amide Compound (3)-FG2] --> P
    K[Carbonylation Process] --> A1(Benzazepine Monomer)
    A1 -->|Polymerization Reaction| SP(Specialty Polymer)
    P --> SP
    subgraph Functional Groups (FG)
        FG1[Polymerizable Group 1]
        FG2[Polymerizable Group 2]
    end
```

Derivative 1.7: Agrochemical Active Intermediate Synthesis

Enabling Description: The core carbonylation chemistry is applied to synthesize novel benzazepine derivatives as intermediates for agrochemical active ingredients. For example, a benzazepine compound (1) bearing specific halogen or alkyl substituents relevant to pesticidal activity is generated via the described carbonylation. This intermediate is then further functionalized (e.g., via Suzuki coupling, amidation, or alkylation) to produce final agrochemical products such as insecticides, fungicides, or herbicides with improved efficacy or environmental profiles.
```
graph TD
    S[Starting Precursors] --> R1(Carbonylation Process)
    R1 --> I(Benzazepine Intermediate (1))
    I --> R2(Further Functionalization)
    R2 --> AG(Agrochemical Active Ingredient)
```

Derivative 1.8: Ligand Synthesis for Catalysis in Energy Applications

Enabling Description: Benzazepine compounds (1) are synthesized with specific functional groups (e.g., phosphine, N-heterocyclic carbene precursors, pyridine) incorporated into R1 or R2. These modified benzazepine structures act as novel chiral or achiral ligands. The carbonylation process is optimized for efficiency and purity for this purpose. These benzazepine-derived ligands are then complexed with transition metals (e.g., Ru, Ir, Ni) and employed as catalysts in energy-related applications, such as hydrogen production/storage, CO2 reduction, or selective biomass conversion reactions.
```
graph TD
    A[Compound (2)-LG_Precursor] --> C(Carbonylation Process)
    C[Amide Compound (3)] --> C
    C --> L(Benzazepine Ligand)
    L --> D(Metal Complexation)
    D --> CA(Catalyst for Energy Applications)
```

4. Integration with Emerging Tech

Derivative 1.9: AI-Driven Optimization of Carbonylation Parameters with IoT Sensors

Enabling Description: The carbonylation reaction is conducted in a smart reactor equipped with IoT sensors that provide real-time data on temperature, pressure, reactant concentrations (via in situ FTIR or Raman spectroscopy), and CO uptake. This data is fed into an AI-driven optimization algorithm (e.g., Bayesian optimization or reinforcement learning) that adjusts reaction parameters (e.g., temperature profile, CO partial pressure, catalyst loading, reactant feed rates) in real-time to maximize yield and purity of benzazepine compound (1) while minimizing side product formation. A digital twin model of the reaction is used for predictive control.
```
graph TD
    R(Smart Reactor) --> |Sensor Data| IoT[IoT Platform]
    IoT --> AI[AI Optimization Algorithm]
    AI --> |Control Signals| R
    R -- Reaction Progress --> RP(Real-time Analytics)
    RP --> |Yield, Purity| AI
    subgraph Parameters
        A[Temperature]
        B[Pressure]
        C[Concentration]
        D[CO Uptake]
    end
    R -- Measures --> A, B, C, D
```

Derivative 1.10: Blockchain for Catalyst Supply Chain Verification in GMP Synthesis

Enabling Description: In the Good Manufacturing Practice (GMP) synthesis of benzazepine compound (1), the entire supply chain for the palladium catalyst and expensive phosphine ligands is immutably recorded on a blockchain. Each batch of catalyst, ligand, and starting material is assigned a unique cryptographic hash and tracked from raw material sourcing, through synthesis and purification, to delivery at the manufacturing facility. IoT sensors embedded in packaging record environmental conditions during transport. This provides an auditable, tamper-proof record of material provenance, purity, and storage conditions, ensuring regulatory compliance and preventing counterfeiting for high-value pharmaceutical intermediates.
```
sequenceDiagram
    participant SM as Starting Material Supplier
    participant CS as Catalyst Supplier
    participant BL as Blockchain Ledger
    participant MF as Manufacturing Facility
    SM ->> BL: Record batch details (compound (2), (3))
    CS ->> BL: Record catalyst/ligand batch details
    MF ->> BL: Record IoT data (transport conditions)
    MF ->> BL: Record incoming quality control (QC) results
    MF ->> MF: Use verified materials in carbonylation
    MF ->> BL: Record in-process control (IPC) data for reaction
    BL -->> MF: Verify material provenance & quality
    BL -->> Auditor: Provide immutable audit trail
```

5. The "Inverse" or Failure Mode

Derivative 1.11: Controlled Partial Carbonylation for Library Synthesis

Enabling Description: The carbonylation process is intentionally modified to achieve controlled incomplete conversion of compound (2) or amide compound (3), resulting in a reaction mixture rich in intermediates that are precursors to benzazepine compound (1) or novel side products. This is achieved by using sub-stoichiometric amounts of the carbonylating agent (CO) (e.g., 0.1-0.5 equivalents relative to the limiting reactant), reduced catalyst loading, or significantly shortened reaction times. The resulting partially converted mixtures are designed for direct screening in combinatorial libraries or for the synthesis of analogs with subtle structural differences, rather than for optimal yield of compound (1).
```
graph TD
    A[Compound (2)] --> R(Reactor)
    C[Amide Compound (3)] --> R
    K[Low Catalyst] --> R
    G[Sub-Stoichiometric CO] --> R
    R --> I1(Unreacted (2))
    R --> I2(Unreacted (3))
    R --> I3(Partially Reacted Intermediates)
    R --> P(Low Yield Compound (1))
    I1, I2, I3, P --> L[Combinatorial Library]
```

Derivative 1.12: Low-Power, Rate-Limited Carbonylation for Kinetic Studies

Enabling Description: The carbonylation process is executed under conditions deliberately chosen for low reaction rates and limited conversion, such as very low temperatures (e.g., -20 to 20° C.), minimal catalyst concentrations (e.g., 0.001-0.005 mol% Pd), and inert solvents that do not promote high reactivity. This "low-power" mode is specifically designed not for production, but for detailed kinetic and mechanistic investigations, allowing for the precise monitoring of intermediate formation, catalyst deactivation pathways, and energy profiles. The data collected facilitates a deeper understanding of the reaction mechanism without uncontrolled exothermic events.
```
graph TD
    A[Compound (2)] --> R(Kinetic Study Reactor)
    C[Amide Compound (3)] --> R
    K[Minimial Catalyst] --> R
    G[Low Temperature, Pressure] --> R
    R --> S1(Sampling Port 1)
    R --> S2(Sampling Port 2)
    S1, S2 --> A(Analytical Instruments)
    A --> D[Kinetic Data]
```

Derivatives of Independent Claims 7, 8, 9, 10: Processes for Preparing Benzoic Acid Compound (4)

(Various methods: Reacting (11) with oxalyl halide (19); Oxidizing (12); Hydrolyzing (13); Oxidizing (14))

1. Material & Component Substitution

Derivative 2.1: Enzymatic Oxidation of Amide Compound (12) or (14)

Enabling Description: The oxidation of amide compound (12) or (14) (bearing an alkyl side chain convertible to a carboxylic acid) to benzoic acid compound (4) is performed using an enzymatic biocatalytic system. This could involve whole-cell fermentation with genetically engineered microorganisms expressing relevant monooxygenases or dioxygenases (e.g., cytochrome P450 enzymes) or purified enzyme preparations (e.g., alcohol oxidases, aldehyde dehydrogenases). The reaction is conducted in aqueous buffer systems at mild temperatures (25-45° C.) and physiological pH, offering high chemo-, regio-, and enantioselectivity, and reducing hazardous waste streams.
```
graph TD
    A[Amide Compound (12) or (14)] --> B(Enzyme/Whole-Cell Bioreactor)
    B --> C{Benzoic Acid Compound (4)}
    C --> D[Enzyme/Biomass Separation]
    D --> E[Purification]
```

Derivative 2.2: Solid-Phase Reagent for Oxalyl Halide Reaction (Claim 7)

Enabling Description: The reaction of amide compound (11) with an oxalyl halide (19) (e.g., oxalyl chloride) to yield benzoic acid compound (4) is carried out using a solid-phase equivalent of the activating agent. For instance, a polymer-supported reagent like a polymer-bound sulfonyl chloride or a polymer-bound phosphoryl chloride is employed to in situ activate the carboxylic acid derivative (e.g., from (11)) or facilitate the leaving group removal. This simplifies product isolation by filtration of the spent resin, avoiding the handling of corrosive liquid oxalyl halides and their byproducts.
```
graph TD
    A[Amide Compound (11)] --> R(Reactor with Solid-Phase Reagent)
    B[Oxalyl Halide (19)] --> R
    R --> C{Benzoic Acid Compound (4)}
    C --> D[Filtration of Resin]
    D --> E[Purification]
```

Derivative 2.3: Ionic Liquid-Mediated Hydrolysis of Amide Compound (13) (Claim 9)

Enabling Description: The hydrolysis of amide compound (13) to benzoic acid compound (4) is conducted in an ionic liquid (IL) solvent system. A protic ionic liquid (e.g., 1-butyl-3-methylimidazolium hydrogen sulfate) or a combination of a neutral ionic liquid with a dissolved acid/base catalyst (e.g., [BMIM][PF6] with p-toluenesulfonic acid or NaOH) is used. The reaction is performed at elevated temperatures (80-150° C.). Ionic liquids offer advantages such as non-volatility, high thermal stability, and recyclability, providing a greener alternative to traditional organic solvents for hydrolysis reactions.
```
graph TD
    A[Amide Compound (13)] --> IL(Ionic Liquid Reactor)
    B[Water, Acid/Base Catalyst] --> IL
    IL --> C{Benzoic Acid Compound (4)}
    C --> D[IL Recycling]
    D --> E[Purification]
```

2. Operational Parameter Expansion

Derivative 2.4: Continuous Flow Electrochemical Oxidation of Amide Compound (12) or (14)

Enabling Description: The oxidation of amide compound (12) or (14) to benzoic acid compound (4) is performed using a continuous flow electrochemical cell. The substrate solution (in an appropriate electrolyte and solvent, e.g., acetonitrile with supporting electrolyte like tetrabutylammonium perchlorate) is pumped through the cell, where an applied potential across working and counter electrodes drives the oxidation. The electrodes are fabricated from materials like glassy carbon or platinum. This offers precise control over redox potential, avoiding strong chemical oxidants, and enables safe scale-up by modularizing reactor units.
```
graph LR
    A[Amide Compound (12) or (14) Feed] --> EF(Electrochemical Flow Cell)
    B[Electrolyte Feed] --> EF
    EF -->|Applied Potential| P(Product Stream)
    P --> D{Benzoic Acid Compound (4)}
    D --> E[Separation & Purification]
```

Derivative 2.5: Microwave-Assisted Hydrolysis of Amide Compound (13) (Claim 9)

Enabling Description: The hydrolysis of amide compound (13) to benzoic acid compound (4) is significantly accelerated using microwave irradiation. The reaction mixture (compound (13), water, and acid or base catalyst) is subjected to microwave heating in a sealed reactor. This enables rapid heating to high temperatures (150-250° C.) and pressures, dramatically reducing reaction times from hours to minutes compared to conventional heating methods, improving throughput for industrial synthesis.
```
graph TD
    A[Amide Compound (13)] --> MW(Microwave Reactor)
    B[Water, Acid/Base] --> MW
    MW -->|Rapid Heating| C{Benzoic Acid Compound (4)}
    C --> D[Cooling & Quenching]
    D --> E[Purification]
```

3. Cross-Domain Application

Derivative 2.6: Benzoic Acid Compound (4) for Advanced Pigment Synthesis

Enabling Description: Benzoic acid compounds of Formula (4) are synthesized using the claimed processes (oxidation, hydrolysis, or oxalyl halide reaction) with specific R1/R2 groups that allow for chromophore integration. These derivatives are then used as key building blocks in the synthesis of advanced organic pigments, where the benzamide-benzoic acid scaffold provides a robust, color-fast core. Further functionalization (e.g., condensation with amines, dyes) transforms the compound into pigments for high-performance automotive coatings, textiles, or inkjet inks.
```
graph TD
    S[Starting Materials (11,12,13,14)] --> P(Process (Claim 7,8,9,10))
    P --> I(Benzoic Acid Compound (4))
    I --> F(Further Functionalization to Chromophore)
    F --> AP(Advanced Organic Pigment)
```

Derivative 2.7: Intermediate for Biodegradable Polymer Chain Termination

Enabling Description: Benzoic acid compounds (4) are synthesized (via any of the claimed processes) wherein the R1/R2 substituents are chosen to impart specific biodegradability or biocompatibility. These compounds are then employed as chain-transfer agents or chain-terminating agents in the controlled radical polymerization of biodegradable polymers (e.g., polyesters, polyamides), allowing for precise control over molecular weight and end-group functionality. This finds application in medical devices, sustainable packaging, or controlled-release drug delivery systems.
```
graph TD
    SM[Starting Materials] --> Synth(Synthesis Process (Claim 7,8,9,10))
    Synth --> BAC(Benzoic Acid Compound (4))
    BAC --> P(Polymerization Reactor)
    P --> BDP(Biodegradable Polymer with Controlled End-Group)
```

Derivative 2.8: Surfactant Precursor in Enhanced Oil Recovery

Enabling Description: Benzoic acid compounds (4) are modified (e.g., via esterification or amidation of the carboxylic acid, or functionalization of R1/R2) to create novel amphiphilic molecules. The benzoic acid moiety, synthesized by the claimed processes, serves as a hydrophobic backbone. These derivatives are then tested and optimized as surfactants in enhanced oil recovery (EOR) operations. They effectively lower interfacial tension between oil and water, mobilizing trapped oil in reservoir rock, thereby increasing oil production from mature fields.
```
graph TD
    SM[Starting Materials] --> Synth(Synthesis Process (Claim 7,8,9,10))
    Synth --> BAC(Benzoic Acid Compound (4))
    BAC --> Mod(Amphiphilic Modification)
    Mod --> SUR(Novel Surfactant)
    SUR --> EOR(Enhanced Oil Recovery Application)
```

4. Integration with Emerging Tech

Derivative 2.9: AI-Driven Catalyst Discovery and Reaction Pathway Prediction

Enabling Description: For the oxidation (Claims 8, 10) or hydrolysis (Claim 9) processes, an AI-driven platform is used for de novo catalyst discovery and reaction pathway prediction. Machine learning models, trained on large datasets of reaction outcomes, predict optimal enzymatic or chemical catalysts, solvent systems, and reaction conditions (temperature, pH, pressure) to maximize the yield and selectivity of benzoic acid compound (4). This includes predicting the most efficient precursor ((12), (13), or (14)) and avoiding undesired side reactions.
```
graph TD
    D(Reaction Database) --> ML(Machine Learning Model)
    ML --> P(Catalyst/Pathway Prediction)
    P --> E(Experimental Validation)
    E --> D
    subgraph Input
        A[Amide Compounds (12,13,14)]
        B[Desired Product (4)]
        C[Constraints]
    end
    Input --> ML
```

Derivative 2.10: IoT-Monitored Continuous Flow Reactor for Process Control and Optimization

Enabling Description: The synthesis of benzoic acid compound (4) via oxidation (Claims 8, 10) or hydrolysis (Claim 9) is performed in a continuous flow reactor equipped with an array of IoT sensors. These sensors monitor key process variables such as reactant flow rates, temperature, pressure, pH (for hydrolysis), redox potential (for oxidation), and in-line UV-Vis or HPLC analysis for real-time product/intermediate concentration. This data is transmitted to a central control system, which uses feedback loops and predictive analytics to maintain optimal operating conditions, ensure consistency, and detect deviations for immediate intervention.
```
graph TD
    A[Reactant Feed] --> R(Continuous Flow Reactor)
    R --> |Sensors: Temp, pH, Redox, Conc.| IoT[IoT Monitoring Unit]
    IoT --> C(Control System)
    C --> |Adjustments| R
    R --> P{Benzoic Acid Compound (4) Output}
    subgraph Sensors
        S1[Flow Rate]
        S2[Temperature]
        S3[pH/Redox]
        S4[In-line Analytics]
    end
    R -- Monitored by --> S1, S2, S3, S4
```

5. The "Inverse" or Failure Mode

Derivative 2.11: Partial Hydrolysis/Oxidation for Diversified Intermediate Synthesis

Enabling Description: The hydrolysis (Claim 9) or oxidation (Claims 8, 10) processes are intentionally modulated to achieve partial conversion, yielding a mixture of the target benzoic acid compound (4) along with partially hydrolyzed or oxidized intermediates (e.g., amides, aldehydes, alcohols). This is achieved by using sub-stoichiometric amounts of water or oxidant, reduced reaction times, or milder catalysts. The objective is to generate a diverse set of functionalized intermediates from a single synthetic run, which can then be selectively isolated and further elaborated into a broader range of derivatives than just compound (4).
```
graph TD
    A[Amide Compound (12, 13, or 14)] --> R(Controlled Reaction)
    R --> P1(Partially Oxidized/Hydrolyzed)
    R --> P2(Side Products)
    R --> P3(Target Benzoic Acid (4))
    R --> P4(Unreacted Starting Material)
    P1, P2, P3, P4 --> D[Diverse Intermediate Pool]
```

Derivative 2.12: Energy-Efficient, Low-Yield Production of Benzoic Acid Compound (4)

Enabling Description: A process for generating benzoic acid compound (4) is designed with primary emphasis on minimizing energy consumption, even if it results in significantly lower yields or purity initially. This involves operating the oxidation or hydrolysis reactions at ambient temperature and pressure, utilizing less potent or sub-stoichiometric catalysts, and avoiding energy-intensive purification steps. The resulting crude product, while low in yield and purity, is suitable for applications where high purity is not immediately critical (e.g., initial biological screening, material bulk synthesis where purification is deferred), demonstrating a trade-off for reduced energy footprint.
```
graph TD
    A[Amide Compound (12, 13, or 14)] --> R(Low-Energy Reactor)
    R --> LYS(Low Yield/Purity Product (4))
    LYS --> S[Basic Screening]
    LYS --> BF[Bulk Functionalization]
    R -- Optimized for --> E[Low Energy Consumption]
```

Derivatives of Independent Claim 11: Process for Preparing 2,3,4,5-tetrahydro-1H-1-benzazepine Compound (10)

(Reducing benzazepine compound (1) with hydrogenating agent in 0.1 to 1 mole ratio)

1. Material & Component Substitution

Derivative 3.1: Bio-Reduction with Ketoreductase Enzymes

Enabling Description: The reduction of benzazepine compound (1) (which presumably contains a ketone or imine that is reduced to a hydroxyl or amine in compound (10)) is catalyzed by isolated ketoreductase (KRED) enzymes or whole-cell biocatalysts (e.g., engineered yeast or bacteria). The reaction is performed in an aqueous buffer system (pH 6-8) at mild temperatures (20-40° C.) with a cofactor regeneration system (e.g., glucose dehydrogenase for NADPH regeneration). This provides high enantioselectivity for chiral centers in compound (10), minimizes dehalogenation, and avoids harsh chemical reducing agents. The stoichiometry of the KRED is catalytic, with the limiting factor being substrate concentration or cofactor turnover.
```
graph TD
    A[Benzazepine Compound (1)] --> BR(Bioreactor with KRED/Whole Cells)
    B[Cofactor Regeneration System] --> BR
    BR --> C{2,3,4,5-tetrahydro-1H-1-benzazepine Compound (10)}
    C --> D[Enzyme/Cell Separation]
    D --> E[Purification]
```

Derivative 3.2: Transfer Hydrogenation with Formic Acid/Salts

Enabling Description: The reduction of benzazepine compound (1) to compound (10) is achieved via catalytic transfer hydrogenation. Instead of direct H2 gas or metal hydrides, a hydrogen donor like formic acid, ammonium formate, or sodium formate is used in conjunction with a ruthenium or iridium catalyst (e.g., [RuCl2(p-cymene)]2 or [IrCp*Cl2]2 dimers with chiral diamine ligands). The reaction is conducted in a polar protic solvent (e.g., isopropanol, water) at temperatures from 50-100° C. This method avoids the need for specialized high-pressure hydrogenation equipment and offers a selective reduction pathway.
```
graph TD
    A[Benzazepine Compound (1)] --> R(Transfer Hydrogenation Reactor)
    B[Formic Acid/Salt] --> R
    C[Ru/Ir Catalyst] --> R
    R --> D{2,3,4,5-tetrahydro-1H-1-benzazepine Compound (10)}
    D --> E[Purification]
```

Derivative 3.3: Boron Hydride Polymers as Solid-Supported Reducing Agents

Enabling Description: The reduction of benzazepine compound (1) is performed using a polymeric reagent incorporating borohydride functionality, such as a poly(4-vinylpyridine)-supported borohydride complex. The insoluble polymer acts as a heterogeneous reducing agent, allowing for easy separation by filtration after the reaction. The stoichiometric ratio is maintained by controlling the loading of borohydride sites on the polymer. This facilitates workup and avoids the handling of pyrophoric or highly reactive soluble metal hydrides, enhancing process safety and scalability.
```
graph TD
    A[Benzazepine Compound (1)] --> R(Reactor with Polymer-Supported Borohydride)
    R --> C{2,3,4,5-tetrahydro-1H-1-benzazepine Compound (10)}
    C --> D[Filtration of Polymer]
    D --> E[Purification]
```

2. Operational Parameter Expansion

Derivative 3.4: High-Throughput Microplate-Based Reduction Screening

Enabling Description: The reduction of benzazepine compound (1) to compound (10) is optimized using a high-throughput screening platform in 96-well or 384-well microplates. Automated liquid handlers dispense small volumes (µL scale) of compound (1), various hydrogenating agents (LiAlH4, NaBH4, Zn(BH4)2, diborane precursors), catalysts, and solvents at varying molar ratios (0.1 to 1 equivalent, plus broader ranges to explore selectivity). Each well represents a unique reaction condition, allowing for rapid identification of optimal conditions (minimal dehalogenation, maximal yield, desired stereoselectivity) using robotic analytical techniques (e.g., plate-based HPLC-MS).
```
graph TD
    S(Stock Solutions) --> L(Automated Liquid Handler)
    L --> MP(Microplate Reactor)
    MP --> A(Automated Analytics)
    A --> D[Data Analysis & Optimization]
    subgraph Variables
        V1[Hydrogenating Agent Type]
        V2[Molar Equivalent (0.1-1)]
        V3[Solvent]
        V4[Temperature]
    end
    MP -- Varies --> V1, V2, V3, V4
```

Derivative 3.5: Supercritical Hydrogenation (SuperH2) for Enhanced Selectivity

Enabling Description: The reduction of benzazepine compound (1) to compound (10) is performed using supercritical hydrogen (SuperH2) as the reducing agent, in conjunction with a heterogeneous catalyst (e.g., Pt/C or Pd/C). Operating above the critical point of hydrogen (12.9 bar, -240° C.) at elevated temperatures (50-150° C.) and pressures (100-300 bar), SuperH2 exhibits enhanced solubility in organic substrates and improved mass transfer. This leads to higher reaction rates, reduced catalyst loading, and potentially greater selectivity in avoiding dehalogenation due to different kinetic profiles under supercritical conditions.
```
graph TD
    A[Benzazepine Compound (1)] --> SHR(Supercritical Hydrogenation Reactor)
    B[H2 (Supercritical)] --> SHR
    C[Heterogeneous Catalyst] --> SHR
    SHR --> D{2,3,4,5-tetrahydro-1H-1-benzazepine Compound (10)}
    D --> E[Depressurization Separation]
    E --> F[Purification]
```

3. Cross-Domain Application

Derivative 3.6: Hydrogenation of Bio-Renewable Feedstocks for Fuels/Chemicals

Enabling Description: The selective hydrogenation principles (0.1 to 1 mole ratio of hydrogenating agent to substrate) established for benzazepine compound (1) are directly applied to the reduction of specific functional groups in bio-renewable feedstocks (e.g., ketones, aldehydes, unsaturated bonds in lignin derivatives or bio-oils). This aims to produce platform chemicals, biofuels, or value-added biochemicals from sustainable sources, while minimizing over-reduction or side reactions that lead to undesirable byproducts. The precise control of reducing agent stoichiometry is critical to achieving specific product profiles.
```
graph TD
    BRF[Bio-Renewable Feedstock] --> HR(Hydrogenation Reactor)
    HR -->|Controlled Reducing Agent (0.1-1 eq)| PC(Platform Chemicals/Biofuels)
    PC --> FV[Fuel/Chemical Valorization]
```

Derivative 3.7: Controlled Reduction in Polymer Degradation/Recycling

Enabling Description: The controlled reduction methodology (using sub-stoichiometric hydrogenating agent amounts) is employed in processes for the selective chemical recycling or degradation of polymers. For instance, specific reducible linkages or functional groups within a polymer chain are targeted, while other groups are preserved. This allows for controlled depolymerization or modification, yielding valuable monomers or oligomers without completely destroying the polymer backbone, which can then be reused or reprocessed. The 0.1 to 1 mole ratio control prevents excessive degradation.
```
graph TD
    PM[Polymer Material] --> CDR(Controlled Degradation/Reduction)
    CDR -->|0.1-1 eq Reducing Agent| OMO(Oligomers/Monomers)
    OMO --> RC[Recycling/Reprocessing]
```

Derivative 3.8: Fine Chemical Synthesis for OLED Materials

Enabling Description: The reduction process described (Claim 11) is used to synthesize 2,3,4,5-tetrahydro-1H-1-benzazepine compounds (10) where the R1, R2, or X1 substituents are modified to incorporate chromophoric or emissive properties, making them suitable as building blocks for organic light-emitting diode (OLED) materials. The high purity and selective reduction achieved by the specified molar ratio of hydrogenating agent are critical to ensure the desired electronic properties and minimize defects in the final OLED device, which are sensitive to impurities.
```
graph TD
    BC[Benzazepine Compound (1) - OLED Precursor] --> R(Reduction Process (Claim 11))
    R --> THC[2,3,4,5-tetrahydro-1H-1-benzazepine (10) - OLED Building Block]
    THC --> OLEDM[OLED Material Synthesis]
    OLEDM --> OLEDD[OLED Device Fabrication]
```

4. Integration with Emerging Tech

Derivative 3.9: AI-Predicted Solvent/Hydride Combinations and IoT Monitoring

Enabling Description: An AI model (e.g., using Quantitative Structure-Property Relationships (QSPR) and machine learning) is developed to predict the optimal solvent system and specific combination of hydrogenating agent (e.g., NaBH4 variants, LiAlH4) to achieve the highest yield and minimal dehalogenation in the reduction of benzazepine compound (1). This prediction is based on the specific substituents R1, R2, and X1. The reaction is monitored by IoT sensors providing real-time spectroscopic data (e.g., NIR for hydride consumption, Raman for product/impurity formation), feeding back to the AI for adaptive adjustments to maintain optimal conditions.
```
graph TD
    D(Reaction Data, Compound Structures) --> AI[AI Predictive Model]
    AI --> P(Optimal Solvent/Hydride Prediction)
    R(Reactor) --> |IoT Sensor Data| IOT[IoT Platform]
    IOT --> C(Control System)
    C --> |Adaptive Adjustments| R
    P --> R
    R -- Yield, Purity --> F[Feedback to AI]
```

Derivative 3.10: Blockchain for Traceability of Deuterated Reducing Agents for Metabolite Synthesis

Enabling Description: In the synthesis of selectively deuterated analogs of compound (10) for pharmacokinetic studies or as internal standards in quantitative analysis, the provenance and purity of deuterated hydrogenating agents (e.g., NaBD4, LiAlD4, D2-gas) are tracked using a blockchain. Each batch of deuterated reagent, from isotopic enrichment to delivery, has its isotopic purity, synthesis route, and storage conditions immutably recorded. This blockchain ledger ensures forensic-level traceability and authenticity, critical for regulatory compliance and the reliability of analytical methods that rely on deuterated standards.
```
sequenceDiagram
    participant IRA as Isotopic Reagent Supplier
    participant BL as Blockchain Ledger
    participant R&D as R&D Lab (Metabolite Synthesis)
    IRA ->> BL: Record deuterated reagent batch details (purity, origin)
    BL -->> R&D: Provide immutable certificate of analysis
    R&D ->> R&D: Use verified deuterated reagents for reduction
    R&D ->> BL: Record reaction parameters & analytical results (MS, NMR)
    BL -->> Auditor: Enable comprehensive audit of deuterated standard production
```

5. The "Inverse" or Failure Mode

Derivative 3.11: Partial Reduction for Synthesis of Novel Precursors

Enabling Description: The reduction process of benzazepine compound (1) (e.g., a ketone) is designed to halt at an intermediate stage, yielding a partially reduced product (e.g., a hemiacetal or a less-reduced alcohol) rather than the fully reduced compound (10). This is achieved by precise control of the hydrogenating agent stoichiometry (e.g., 0.05-0.1 equivalents, or using a very weak reducing agent), short reaction times, or temperature quenching. The partially reduced compound serves as a novel precursor for further derivatization, allowing access to a wider chemical space of benzazepine scaffolds than just compound (10).
```
graph TD
    A[Benzazepine Compound (1) (Ketone)] --> R(Controlled Reduction)
    R --> PR(Partially Reduced Product)
    PR --> F[Further Functionalization]
    F --> NBP(Novel Benzazepine Products)
    R -- Conditions --> S[Sub-stoichiometric Reductant, Short Time]
```

Derivative 3.12: Slow, Non-Selective Reduction for Degradation Studies

Enabling Description: The reduction of benzazepine compound (1) is intentionally performed under conditions that lead to slow reaction rates and poor selectivity, primarily for studying degradation pathways or the long-term stability of the molecule under reductive stress. This involves using highly diluted reagents, weak reducing agents (e.g., catalytic H2/Pd in presence of mild poisoning agents, or a very dilute NaBH4 solution at low temperature), or highly unoptimized solvents. The "failure" here is a lack of high yield/purity, but the goal is to observe and characterize all possible degradation and side-reaction products, including dehalogenation products, to understand compound stability and impurity profiles.
```
graph TD
    A[Benzazepine Compound (1)] --> R(Degradation Study Reactor)
    R --> |Weak/Dilute Reductant| SP1(Dehalogenated Product)
    R --> SP2(Over-reduced Product)
    R --> SP3(Other Side Products)
    R --> PR(Poor Yield Target Product (10))
    SP1, SP2, SP3, PR --> A(Analytical Characterization)
    A --> D[Degradation Pathway Data]
```

Combination Prior Art Scenarios with Open-Source Standards

Here are at least three scenarios where the processes disclosed in US Patent 8,273,735, and their derivatives, could be combined with existing open-source standards to establish further prior art.

1. Integration with Open-Source Cheminformatics for Reaction Design & Optimization

Scenario: The processes for synthesizing benzazepine compounds (1) (Claim 1), benzoic acid compounds (4) (Claims 7-10), and tetrahydro-benzazepine compounds (10) (Claim 11) are implemented and optimized using an open-source cheminformatics platform.
Enabling Description: Reaction conditions (solvents, catalysts, temperatures, reactant ratios like the 0.1-1 mole for reduction in Claim 11) for all claimed processes are modeled and predicted using open-source cheminformatics toolkits such as RDKit or OpenBabel. For example, RDKit's reaction functionality is used to enumerate possible reactants and products, predict reaction outcomes, and calculate molecular descriptors. These descriptors are then fed into open-source machine learning libraries (e.g., Scikit-learn) to build predictive models for yield, purity, and byproduct formation based on experimental data. Furthermore, automated retrosynthesis algorithms (e.g., those implemented in AiZynthFinder, an open-source tool) are used to explore alternative synthetic routes for compounds (1), (4), and (10), making any future claims on minor variations of known synthetic strategies obvious. This entire workflow, including data handling and visualization, adheres to open-source data exchange formats like SMILES and InChI strings for chemical structures.
```
graph TD
    A[Claimed Reaction Steps] --> RDKit[RDKit for Reaction Modeling]
    D[Experimental Data] --> SKL[Scikit-learn for Predictive Models]
    RDKit --> SKL
    SKL --> O[Optimized Reaction Parameters]
    O --> E[Execute Reaction]
    AiZF[AiZynthFinder for Retrosynthesis] --> A
    subgraph Open-Source Tools
        RDKit
        SKL
        AiZF
    end
```

2. Open-Source Electronic Laboratory Notebook (ELN) for Process Documentation

Scenario: All experimental procedures, raw data, and analytical results generated during the development and execution of the processes claimed in US8273735 are meticulously documented within an open-source Electronic Laboratory Notebook (ELN) system.
Enabling Description: Researchers utilize an open-source ELN platform, such as OS-ELN (Open Source Electronic Lab Notebook) or a custom ELN built using open-source web frameworks (e.g., Django or Flask). This system captures every detail of the chemical reactions, including exact reagent quantities (especially the critical 0.1 to 1 mole ratio for the hydrogenating agent in Claim 11), solvent volumes, reaction temperatures, stirring rates, catalyst batch numbers, and purification protocols. Analytical data from instruments (e.g., NMR, HPLC, MS) are automatically imported and timestamped, ensuring data integrity. The ELN adheres to open data formats (e.g., JSON, XML) for experiment descriptions and JCAMP-DX for spectroscopic data, facilitating interoperability and public sharing of methods. This comprehensive, publicly available record of detailed experimental conditions for preparing compounds (1), (4), and (10) makes it difficult to patent minor procedural variations.
```
graph TD
    Exp[Chemical Experiment (Claim 1, 7-11)] --> ELN[Open-Source ELN (e.g., OS-ELN)]
    Anal[Analytical Instruments (HPLC, NMR, MS)] --> ELN
    ELN --> |Timestamped Records| DB(Open-Source Database)
    DB --> |JSON/XML Export| Public[Public Data Repository]
    subgraph Open-Source Standards
        ELN
        DB
        Public
    end
```

3. Automated Synthesis and Optimization with Open-Source Robotics Platform

Scenario: The high-throughput experimentation and scale-up of the claimed chemical processes are performed using an open-source robotics and automation platform, making variations in reaction conditions readily reproducible and published.
Enabling Description: The synthesis of benzazepine and benzoic acid compounds (1, 4, 10) is automated using a liquid handling robot controlled by an open-source operating system and software (e.g., OpenTrons Python API or a custom robotic platform utilizing ROS - Robot Operating System). This system precisely executes multi-step syntheses, including reagent addition, mixing, heating (controlled by open-source PID controllers), and sampling. Automated parameter sweeps are performed for key variables, such as the molar ratio of hydrogenating agent in Claim 11, the type of carbonylating agent in Claim 1, or different oxidizing/hydrolyzing agents in Claims 7-10. Reaction vessels are monitored by low-cost, open-source sensors (e.g., Arduino or Raspberry Pi based temperature/pH probes). All robotic scripts, experimental protocols, and results are published in an open-access repository, providing a detailed and executable record of diverse process conditions.
```
graph TD
    R[Chemical Reagents] --> LHR(Liquid Handling Robot)
    LHR --> WS[Automated Workstation]
    WS --> |Open-Source Sensors| OS_MCU[Open-Source Microcontroller]
    OS_MCU --> ROS[ROS / OpenTrons API]
    ROS --> LHR
    WS -- Synthesizes --> Prod[Compounds (1), (4), (10)]
    Prod --> Pub[Open-Access Repository]
    subgraph Open-Source Platform
        ROS
        LHR
        OS_MCU
    end
```